Population scale genomic initiatives aim to provide a foundation for research, transform healthcare and improve patient care by realizing the promise of precision medicine. Genomics powered precision health is an emerging approach where information about gene variability is used to diagnose and predict disease risk, tailor therapies and reduce medical complications. By analysing population-scale genomic, clinical, and lifestyle data, targeted strategies can be developed for specific individuals to improve outcomes and maximise health while reducing overall healthcare costs.
Join us for a virtual event to explore these topics presented by a range of global thought leaders and learn how precision health is being implemented in a range of countries and healthcare systems.
Please register for the virtual event below.
If you have any queries, please email us at Illumina Marketing Asia Pacific Japan.
Speakers:
Bringing Genomics to the Front Lines of Care in a Community Health System
Dr. Mark Dunnenberger - Director, Pharmacogenomics, Center for Personalized Medicine, NorthShore University Health System, USA
The Value of the Genetics Study in Non-European Population: The BioBank Japan Project
Dr. Yoichiro Kamatani- Professor, The University of Tokyo, Japan
Singapore National Precision Medicine Programme – Pathways to Clinical Implementation and Value Demonstration
Prof. Tai E Shyong - Chief Medical Officer, PRECISE, Singapore
Powering Biopharma Research with Data and Genomics – The Time is Now
Dr. Dae Wook Lee - APAC Regional Portfolio Medical Lead (Rare Hematology, Rare Metabolic, Rare Immunology & Neuroscience), Takeda Pharmaceuticals (Asia Pacific) Pte Ltd